Coronary artery diseases (CAD), a non-communicable disease, pose a formidable healthcare challenge globally, particularly in India. Therefore, the demand for advanced medical interventions continues to rise. Coronary stents (CS) play a pivotal role in managing CAD. Coronary stents CS are generally available as bare-metal and drug-eluting varieties. This research delves into the landscape of coronary stents approved in India, leveraging data from the official website of the Central Drugs Standard Control Organization (CDSCO), which is the national Regulatory Authority for Medical Devices in India. This study provides critical insights for stakeholders, informing strategies for future research, development, and policy formulation in coronary stent technology in India.
No takes yet. Share an insight, caveat, or question.
Dukare et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: